We used transcriptome profiling to characterize gene expression changes and pathways affected by Casp2 deficiency, in tumors from Th-MYCN neuroblastoma30 and EμMyc lymphoma transgenic mouse models7. This evidence concerns the gene CASP2 and lymphoma.